231 unknown. 231 Phase 3, 58 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 231 | Unknown 231 |
| Phase 2 | 58 | Unknown 58 |
Follow Liver Diseases: new trials by email Literature Review of Liver Diseases trials Research Report on Liver Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Aprepitant Plus Granisetron and Dexamethasone for the Prevention of Vomiting in Patients With HAIC Therapy for HCC Aprepitant in combination with granisetron and dexamethasone, Granisetron and dexamethasone - Hepatocellular Carcinoma | Phase 3 | Unknown | Guangxi Medical University | 300 | 2024-07-01 | 2024-01-23 |
| The Safety and Efficacy of Alverine in the Treatment of Cirrhotic Portal Hypertension Alverine - Hypertension, Portal | Phase 2 / Phase 3 | Unknown | Shanghai Changzheng Hospital | 30 | 2024-06-01 | 2024-06-25 |
| The Efficacy and Safety of Alverine in the Treatment of Portal Hypertension in Patients With Liver Cirrhosis Alverine, Carvedilol - Hypertension, Portal | Phase 2 / Phase 3 | Unknown | Shanghai Changzheng Hospital | 178 | 2024-06-01 | 2024-06-24 |
| Adjuvant Tislelizumab Plus Lenvatinib for Patients at High-risk of HCC Recurrence After Curative Resection or Ablation Adjuvant tislelizumab plus lenvatinib, Adjuvant tislelizumab - Hepatocellular Carcinoma, Recurrence | Phase 3 | Unknown | Guangxi Medical University | 200 | 2024-02-15 | 2024-01-23 |
| Glecaprevir/Pibrentasvir for Post-traumatic Stress Disorder Glecaprevir/pibrentasvir, Placebo - PTSD | Phase 2 / Phase 3 | Unknown | White River Junction Veterans Affairs Medical Center | 92 | 2023-12-18 | 2025-04-24 |
| the Efficacy and Safety of Diosmin on Non-diabetic Patients With Non-alcoholic Steatohepatitis. Diosmin, Placebo - Non Alcoholic Steatohepatitis | Phase 3 | Unknown | Tanta University | 48 | 2023-07-10 | 2023-07-12 |
| Electromagnetic Fields Versus Placebo For Child-Pugh A and B Patients With Advanced Hepatocellular Carcinoma TheraBionic Device, Placebo Device, Quality of Life Assessment - Hepatocellular Carcinoma | Phase 2 / Phase 3 | Unknown | THERABIONIC INC. | 166 | 2023-07-01 | 2023-06-28 |
| Comparative Clinical Study to Evaluate the Efficacy and Safety of Rosuvastatin Vs CoQ10 on Nonalcoholic Steatohepatitis Rosuvastatin 20 Mg Oral Tablet, Coenzyme Q10 100 MG Oral Capsule - Nonalcoholic Steatohepatitis | Phase 3 | Unknown | Tanta University | 46 | 2023-06-01 | 2023-05-16 |
| HAIC Combined Withzoledronic Acid for the Prevention of Bone Metastases in Advanced HCC HAIC, Zoledronic acid - Hepatocellular Carcinoma | Phase 3 | Unknown | Sun Yat-sen University | 264 | 2023-05-10 | 2023-05-19 |
| Polidocanol Foam in Hemorrhoidal Disease in Patients With Liver Cirrhosis Polidocanol foam sclerotherapy - Hemorrhoids, Liver Cirrhosis | Phase 2 / Phase 3 | Unknown | Universidade do Porto | 40 | 2023-03-31 | 2023-04-11 |
| Icaritin Soft Capsule Versus Huachansu Tablet in the First-line Treatment of Unresectable Hepatocellular Carcinoma With Poor Conditions and Biomarker Enrichment (Biomarker Enrichment Study of Poor Prognosis HCC Patients, BESTPOP) Icaritin, Huachansu - Hepatocellular Carcinoma | Phase 3 | Unknown | Beijing Shenogen Biomedical Co., Ltd | 261 | 2022-12-12 | 2024-08-07 |
| To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in Healthy Children Aged From 24mons-15yrs Boryung Hepatitis A Vaccine Pre-Filled Syringe Inj. 0.5 mL, HAVRIX 720 Junior 0.5 mL - Hepatitis A, Hep A | Phase 3 | Unknown | Boryung Biopharma Co., Ltd. | 106 | 2022-12-01 | 2022-11-14 |
| the Efficacy and Safety of Rulonilimab in Combination With Lenvatinib in Hepatocellular Carcinoma Rulonilimab+Lenvatinib, Rulonilimab placebo +Lenvatinib - Hepatocellular Carcinoma | Phase 2 / Phase 3 | Unknown | Shandong New Time Pharmaceutical Co., LTD | 576 | 2022-11-11 | 2023-03-10 |
| Comparative Clinical Study Between Empagliflozin Versus Pioglitazone in Non-diabetic Patients With Non-alcoholic Steatohepatitis Pioglitazone 30mg, Empagliflozin 10 MG - Non Alcoholic Steatohepatitis | Phase 3 | Unknown | Tanta University | 56 | 2022-11-01 | 2022-11-04 |
| Effectiveness of Inactive Vitamin D Supplementation in Non-Alcoholic Fatty Liver Disease Patients Cholecalciferol - Non-Alcoholic Fatty Liver Disease | Phase 3 | Unknown | Ain Shams University | 100 | 2022-10-31 | 2022-11-14 |
| TACE Combined With Penpulimab and Anlotinib for Advanced HCC TACE+penpulimab+anlotinib vs. penpulimab+anlotinib - Hepatocellular Carcinoma | Phase 2 / Phase 3 | Unknown | Zhongda Hospital | 109 | 2022-10-12 | 2022-12-29 |
| Zinc Supplementation to Improve Prognosis in Patients With Compensated Advanced Chronic Liver Disease. Zinc Acexamate - Advanced Chronic Liver Disease, Portal Hypertension | Phase 3 | Unknown | Hospital Universitari Vall d'Hebron Research Institute | 300 | 2022-10-02 | 2024-06-04 |
| Research on Optimal Strategy of Hypoglycemic Therapy for Cirrhosis With Diabetes Insulin Degludec and Insulin Aspart - Liver Cirrhosis, Diabetes | Phase 3 | Unknown | Huashan Hospital | 184 | 2022-10-01 | 2022-12-07 |
| Safety and Efficacy of Mitomycin C-based HIPEC After srHCC and PM of HCC mitomycin C-based hyperthermic intraperitoneal chemotherapy - Hepatocellular Carcinoma, Peritoneal Metastasis | Phase 2 / Phase 3 | Unknown | West China Hospital | 68 | 2022-10-01 | 2022-09-16 |
| Efficacy of N-acetylcysteine to Prevent Anti-tuberculosis Drug-induced Liver Injury: A Randomized Controlled Trial N acetyl cysteine - Tuberculosis, Drug Induced Liver Injury | Phase 2 / Phase 3 | Unknown | Mahidol University | 82 | 2022-09-09 | 2023-02-22 |
Showing 20 of 231. Sign in to see all of them.
Carcinoma, Hepatocellular (98) · Hepatitis C (23) · Liver Cirrhosis (20) · Liver Neoplasms (19) · Hepatitis B, Chronic (15) · Hepatitis C, Chronic (14) · Non-alcoholic Fatty Liver Disease (13) · Hypertension, Portal (11) · Fibrosis (9) · Hepatitis B (8) · Hepatitis (6) · Liver Cirrhosis, Biliary (6) · Recurrence (6) · Fatty Liver (5)
Digestive System Diseases (231) · Neoplasms (107) · Neoplasms by Site (107) · Digestive System Neoplasms (106) · Neoplasms by Histologic Type (101) · Adenocarcinoma (98) · Carcinoma (97) · Neoplasms, Glandular and Epithelial (97) · Liver Neoplasms (87) · Pathological Conditions, Signs and Symptoms (74) · Pathologic Processes (71) · Infections (61) · Hepatitis (59) · Virus Diseases (59)
Ribavirin (14) · Sorafenib (13) · lenvatinib (11) · Fluorouracil (9) · peginterferon alfa-2a (9) · Sofosbuvir (8) · Radiofrequency Ablation (7) · Epirubicin (6) · Ethiodized Oil (6) · Tenofovir (6) · Leucovorin (5) · Metformin (5) · Propranolol (5) · Carvedilol (4) · Folfox protocol (4)
Sun Yat-sen University (26) · Guangxi Medical University (12) · Fudan University (8) · Shanghai Zhongshan Hospital (6) · Sherief Abd-Elsalam (6) · Tanta University (6) · All India Institute of Medical Sciences (4) · RenJi Hospital (4) · Ain Shams University (3) · Kaohsiung Veterans General Hospital. (3) · National Taiwan University Hospital (3) · Aga Khan University (2) · Asian Institute of Gastroenterology, India (2) · Clinical Research Organization, Dhaka, Bangladesh (2) · IRCCS San Raffaele (2)
China (91) · Egypt (20) · India (12) · South Korea (12) · Taiwan (11) · Italy (8) · Thailand (6) · Netherlands (5) · Belgium (4) · France (4) · Singapore (4) · Spain (4) · Brazil (3) · Canada (3) · Pakistan (3)
Ming Shi, MD (5) · Jia Fan, MD (4) · Sherief M. Abd-Elsalam, Consultant (3) · Subrat K Acharya, DM (3) · Adriano Lazzarin, MD (2) · Frederik Nevens, MD, PhD (2) · Gao-Jun Teng, MD (2) · Ming Zhao, M.D. & Ph.D. (2) · Sherief Abd-Elsalam, MD (2) · Sherief Abd-Elsalam, lecturer (2) · Walaa A. Elkhalawany, Consultant (2) · Wei-Fen Xie, M.D. (2) · Wei-Zhong Tang, MD (2) · A. K. Singal, Professor (1)
PMID 12049862, PMID 11981766, PMID 12091661, PMID 12540794, PMID 10051462, PMID 10207464, PMID 10215657, PMID 10343514, PMID 10347106, PMID 10400410, PMID 10402169, PMID 10655437, PMID 10671580, PMID 10751477, PMID 10932224, PMID 11050095, PMID 11202797, PMID 11208818, PMID 11211893, PMID 11303974, PMID 11413430, PMID 11419162, PMID 11509137, PMID 11602056, PMID 11727523, PMID 11961194, PMID 12360466, PMID 12508355, PMID 12522441, PMID 12594571, PMID 12616414, PMID 12623635, PMID 12697873, PMID 12727116, PMID 12893895, PMID 14571769, PMID 14630883, PMID 15017671, PMID 15128074, PMID 15273542, PMID 15349904, PMID 15468571, PMID 15753544, PMID 1598671, PMID 16299032, PMID 16305946, PMID 16377509, PMID 16495695, PMID 16530513, PMID 16810012
2014 (1), 2015 (1), 2016 (1), R44CA256984 (1)